Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Atorvastatin
Related studies linked through entity extraction aliases.
A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease
- Status
- TERMINATED
- Phase
- PHASE3
Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
- Status
- TERMINATED
- Phase
- PHASE3
A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Study in People With High Cholesterol
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Evaluate the Effect of Statins on Asthma Control of Patients With Chronic Asthma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)
- Status
- COMPLETED
- Phase
- PHASE4
Lupus Atherosclerosis Prevention Study
- Status
- COMPLETED
- Phase
- PHASE4
Atorvastatin (Lipitor) to Prevent Bone Pain
- Status
- COMPLETED
- Phase
- NA
Rho Kinase in Patients With Atherosclerosis
- Status
- COMPLETED
- Phase
- PHASE3
The Effects of Atorvastatin in Patients With Atherosclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
- Status
- COMPLETED
- Phase
- PHASE4
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
- Status
- COMPLETED
- Phase
- PHASE3
The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
- Status
- UNKNOWN
- Phase
- NA
Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2